Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Semax vs Selank at a Glance

A side-by-side reference for the key differences between these two research peptides. Both are for laboratory research use only. Synthetic analog of ACTH(4-10) Synthetic analog of tuftsin (Thr-Lys-Pro-Arg) Heptapeptide (7 amino acids) Developed in Russia; regi

This comparison does not assign a generated winner or score.

  • A side-by-side reference for the key differences between these two research peptides. Both are for laboratory research use only.
  • Synthetic analog of ACTH(4-10)
  • Synthetic analog of tuftsin (Thr-Lys-Pro-Arg)
  • Heptapeptide (7 amino acids)
  • Developed in Russia; registered in Russia and Ukraine
  • Developed in Russia; registered in Russia
  • Cognitive function, neuroprotection, BDNF modulation
  • Anxiolytic activity, stress response, immunomodulation
  • BDNF and NGF upregulation; dopamine/serotonin modulation
  • GABAergic modulation; enkephalin degradation inhibition
  • Stroke recovery, cognitive impairment, ADHD-analog models
  • Anxiety and stress models, immune modulation
  • Nasal spray, injectable vial
  • Short in plasma; intranasal delivery studied for CNS access
  • Short in plasma; rapidly metabolized
  • Moderate; some published clinical data from Eastern Europe
  • Moderate; primarily animal models, limited clinical trials
  • Registered as a drug in Russia for neurological indications
  • Registered as a drug in Russia; not approved in US/EU
More references

Related material

Comparison

semax vs selank

semax vs selank Semax vs Selank: A Comprehensive Research Peptide Comparison for 2025 Imagine unlocking your brain's full potential with just a few drops of a carefully engineered…

View details →